Search

STAAR Surgical Co

Geschlossen

BrancheGesundheitswesen

23.42 -3.26

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

23.42

Max

24.27

Schlüsselkennzahlen

By Trading Economics

Einkommen

5.2M

5.2M

Verkäufe

36M

94M

EPS

0.29

Gewinnspanne

5.567

Angestellte

921

EBITDA

19M

10M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+29.52% upside

Dividenden

By Acuity

Nächstes Ergebnis

12. Aug. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-192M

1.2B

Vorheriger Eröffnungskurs

26.68

Vorheriger Schlusskurs

23.42

Nachrichtenstimmung

By Acuity

53%

47%

250 / 340 Ranking in Healthcare

STAAR Surgical Co Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

22. Juli 2026, 18:11 UTC

News

Wedbush reiterated its OUTPERFORM rating on STAAR Surgical, maintaining a $40 price target, contributing to shares trading higher today.

21. Juli 2026, 16:56 UTC

Social Media

STAAR Surgical preannounces second-quarter revenue over $90 million, up from $44.3 million last year, as shares gain amid market volatility.

20. Juli 2026, 20:01 UTC

News

STAAR Surgical shares are lower amid investor concerns over sustainability despite projected Q2 sales exceeding $90 million and strong growth in China and the Americas.

Peer-Vergleich

Kursveränderung

STAAR Surgical Co Prognose

Kursziel

By TipRanks

29.52% Vorteil

12-Monats-Prognose

Durchschnitt 31.33 USD  29.52%

Hoch 40 USD

Tief 25 USD

Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für STAAR Surgical Co – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

8 ratings

2

Buy

6

Halten

0

Sell

Stimmung

By Acuity

250 / 340 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
help-icon Live chat